| scholarly article | Q13442814 |
| P50 | author | Sarah Falk | Q30512425 |
| Kirsty Bannister | Q59546587 | ||
| P2093 | author name string | Anthony H Dickenson | |
| P2860 | cites work | Bisphosphonates: mechanism of action and role in clinical practice | Q24644708 |
| Prevalence of undertreatment in cancer pain. A review of published literature | Q24646347 | ||
| COX-2 and PGE2-dependent immunomodulation in breast cancer | Q27003937 | ||
| Molecular mechanisms of nociception | Q28216291 | ||
| Microenvironmental regulation of metastasis | Q29547660 | ||
| A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: therapeutic opportunity for treating skeletal pain. | Q33779598 | ||
| Review of cellular mechanisms of tumor osteolysis. | Q33918064 | ||
| Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur | Q33960259 | ||
| Bone cancer pain. | Q34120101 | ||
| Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain | Q34356398 | ||
| Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. | Q34559758 | ||
| Clinical features of metastatic bone disease and risk of skeletal morbidity | Q34576366 | ||
| Neural coding of nociceptive stimuli-from rat spinal neurones to human perception | Q34747141 | ||
| Impact and management of breakthrough pain in cancer | Q34975545 | ||
| Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain | Q35421746 | ||
| Complex regional pain syndrome: mystery explained? | Q35565725 | ||
| The pathophysiology of cancer-induced bone pain: current understanding | Q35805721 | ||
| Clinical development of anti-RANKL therapy | Q35901092 | ||
| Sensory and affective pain descriptors respond differentially to pharmacological interventions in neuropathic conditions | Q47429483 | ||
| Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? | Q47612494 | ||
| A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee. | Q50961307 | ||
| Bone Cancer Pain | Q54152925 | ||
| Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. | Q54325500 | ||
| Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers | Q73262130 | ||
| Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain | Q73263697 | ||
| A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain | Q73718299 | ||
| Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord | Q73766127 | ||
| Setting the tone: superficial dorsal horn projection neurons regulate pain sensitivity | Q80579148 | ||
| Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms | Q36057778 | ||
| Pregabalin suppresses spinal neuronal hyperexcitability and visceral hypersensitivity in the absence of peripheral pathophysiology | Q36189369 | ||
| Neurotrophins: mediators and modulators of pain. | Q36507606 | ||
| Preclinical and early clinical investigations related to monoaminergic pain modulation | Q37374356 | ||
| Intrathecal substance P-saporin in the dog: efficacy in bone cancer pain | Q37404162 | ||
| Opioid hyperalgesia | Q37658232 | ||
| Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis | Q37800534 | ||
| Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit | Q37987626 | ||
| Combination pharmacotherapy for management of chronic pain: from bench to bedside | Q38145752 | ||
| Pain and nociception: mechanisms of cancer-induced bone pain | Q38209631 | ||
| Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain | Q38446521 | ||
| Pain without nociceptors? Nav1.7-independent pain mechanisms. | Q38552593 | ||
| Spinal neuronal correlates of tapentadol analgesia in cancer pain: a back-translational approach | Q38985991 | ||
| Tapentadol in cancer pain management: a prospective open-label study | Q39240254 | ||
| Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice | Q39341698 | ||
| A rat model of bone cancer pain | Q39598653 | ||
| The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin | Q39753024 | ||
| NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. | Q40345535 | ||
| Evidence of a role for descending serotonergic facilitation in a rat model of cancer-induced bone pain | Q40356924 | ||
| Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. | Q40477180 | ||
| Bone cancer pain model in mice: evaluation of pain behavior, bone destruction and morphine sensitivity | Q40500664 | ||
| Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain | Q40610103 | ||
| An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain | Q40797392 | ||
| Prostaglandin-induced neuropeptide release from spinal cord. | Q40940941 | ||
| Effect of oral pregabalin on opioid-induced hyperalgesia in patients undergoing laparo-endoscopic single-site urologic surgery | Q41986421 | ||
| p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia | Q42526677 | ||
| Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats | Q42923060 | ||
| Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery | Q42943232 | ||
| Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors | Q43880333 | ||
| A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy | Q43901864 | ||
| No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia | Q43905476 | ||
| Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. | Q44037083 | ||
| Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways | Q44195579 | ||
| Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain | Q44198269 | ||
| Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. | Q44266721 | ||
| Tolerance and opioid-induced hyperalgesia. Is a divorce imminent? | Q44334303 | ||
| The endogenous opioid system is not involved in modulation of opioid-induced hyperalgesia | Q44347880 | ||
| Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia | Q44350955 | ||
| Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain. | Q44390920 | ||
| Blocking the effects of NGF as a route to safe and effective pain relief--fact or fancy? | Q45162445 | ||
| How the osteoclast degrades bone | Q46291417 | ||
| Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. | Q46402734 | ||
| Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain | Q46427425 | ||
| Efficacy of chronic morphine in a rat model of cancer-induced bone pain: behavior and in dorsal horn pathophysiology | Q46834653 | ||
| Size, neurochemistry, and segmental distribution of sensory neurons innervating the rat tibia | Q47173706 | ||
| P433 | issue | 4 | |
| P921 | main subject | cancer pain | Q3712728 |
| P304 | page(s) | 154-162 | |
| P577 | publication date | 2014-11-01 | |
| P1433 | published in | British Journal of Pain | Q27725960 |
| P1476 | title | Cancer pain physiology | |
| P478 | volume | 8 |
| Q38684768 | Bone Pain and Muscle Weakness in Cancer Patients |
| Q36195274 | Cancer pain for the 21st century: stepping off the ladder, stepping up to new challenges |
| Q58102355 | Mechanisms Underlying Bone and Joint Pain |
| Q91806283 | Methadone in Swedish specialized palliative care-Is it the magic bullet in complex cancer-related pain? |
| Q42323578 | Repetitive Transcranial Magnetic Stimulation as a Promising Potential Therapeutic Modality for the Management of Cancer-related Pain: An Issue that Merits Further Research. |
| Q33710457 | Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial |
Search more.